Literature DB >> 9714696

p53 and p21(WAF1) expression in lymphocytic thyroiditis and thyroid tumors.

I Okayasu1, T Osakabe, M Onozawa, T Mikami, M Fujiwara.   

Abstract

To clarify the roles of increased apoptosis and cell proliferation in chronic autoimmune lymphocytic thyroiditis and thyroid tumorigenesis, expression of p53 and p21(WAF1) proteins was immunohistochemically investigated in a series of 158 cases. Positive epithelial cells were quantified to give numbers per unit square and to score for distribution. They were found scattered in nontumorous thyroid tissue, their numbers increasing with the severity of thyroiditis and the correlation between expression of the two proteins, regardless of the presence or absence of thyroid neoplasms. Simultaneous expression of both proteins was occasionally found in the same cells by analysis of serial histologic sections. In thyroid tumors, increased expression was found to be diffuse, focal, or scattered for the distribution of p53- or p21(WAF1)-immunopositive cells in accordance with tumor cell dedifferentiation, showing significant correlation between expression of the two proteins. Correlated with these findings, enhanced apoptosis along with decreased Bcl-2 expression and increased Ki-67 labeling in lymphocytic thyroiditis and thyroid tumors was also confirmed in the same series, using in situ DNA nick-end labeling and immunohistochemical methods. Increased expression of p53 and/or p21(WAF1) proteins was thus suggestive of possible DNA damage and increased apoptosis in autoimmune thyroiditis. In addition, a significant correlation between protein overexpression and dedifferentiation of thyroid tumor cells was apparent. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714696     DOI: 10.1006/clin.1998.4572

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Tzu-Yuan Wang; Wen-Liang Huang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  Expression of p21cip1, p27kip1, and p16INk4a cyclin-dependent kinase inhibitors in papillary thyroid carcinoma: correlation with clinicopathological factors.

Authors:  Carles Zafon; Gabriel Obiols; Josep Castellví; Santiago Ramon y Cajal; Juan Antonio Baena; Jordi Mesa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  p27 Kip1 protein expression in Hashimoto's thyroiditis.

Authors:  G Troncone; A Iaccarino; A Caleo; D Bifano; G Pettinato; L Palombini
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

4.  p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues.

Authors:  Lori A. Erickson
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

5.  Apoptosis and p53 expression in rat adjuvant arthritis.

Authors:  P P Tak; M S Klapwijk; S F Broersen; D A van de Geest ; M Overbeek; G S Firestein
Journal:  Arthritis Res       Date:  2000-03-01

6.  K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.

Authors:  K Yamashita; Y Kida; H Shinoda; M Kida; I Okayasu
Journal:  Jpn J Cancer Res       Date:  1999-02

7.  Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.

Authors:  Ohoud Subhi; Hans-Juergen Schulten; Nadia Bagatian; Roa'a Al-Dayini; Sajjad Karim; Sherin Bakhashab; Reem Alotibi; Alaa Al-Ahmadi; Manar Ata; Aisha Elaimi; Saad Al-Muhayawi; Majid Mansouri; Khalid Al-Ghamdi; Osman Abdel Hamour; Awatif Jamal; Jaudah Al-Maghrabi; Mohammed Hussain Al-Qahtani
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.